Anemia a esclarecer – Parte 2

Moreira LBM, Melo ASA, Pinheiro RA, Crespo SJV, Marchiori E. Pseudomixoma peritoneal: aspectos tomográficos e na ressonância magnética: relato de três casos. Radiol Bras. 2001;34(3):181-6.

Bochi C, Buhler R, Buhler JA. Pseudomixoma peritonei: relato de caso e revisão da literatura. Sci Med. 2007;17(1):36-9.

Bevan KE, Mohamed F, Moran BJ. Pseudomyxoma peritonei. World J Gastrointest Oncol. 2010;2(1):44-50.

Sulkin TV, O'Neill H, Amin AI, Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002;57:608-13.

Jivan S, Baha V. Case reports: Pseudomyxoma peritonei. Postgrad Med J. 2002;78:170-2.

Guo AT, Song X, Wei LX, Zhao P. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry. World J Gastroenterol. 2011;17(30):3531-7.

Cioppa T, Vaira M, Bing C, D'Amico S, Bruscino A, Simone M. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei. World J Gastroenterol. 2008;14(44):6817-23.

Sugarbaker PH, D Chang. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727-31.

Farquharson AL, Pranesh N, Witham G, Swindell R, Taylor MB, Renehan AG, et al. A phase ii study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer. 2008;99(4):591-6.

Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484-92.

Deraco M, Kusamura S, Laterza B, Favaro M, Fumagalli L, COtanzo P, et al. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center. Int J Exp Clin Pathophysiol Drug Res. 2006;20:773-6.

Chen CF, Huang CJ, Kang WY, Hsieh JS. Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (folfox4). World J Surg Oncol. 2008;6:118.

Sun WL, Hutarew G, Gradl J, Gratzl M, Denz H, Fiegl M. Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabin. Cancer Biol Ther. 2009;8(15):1459-62.

Dixit A, Robertson JHP, Mudan SS, Akl C. Case report: appendiceal mucocoeles and pseudomyxoma peritonei. World J Gastroenterol. 2007;13(16):2381-4.